Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy Christina M. CoughlinDaniel S. JohnstonAnna Berkenblit Review 28 August 2010 Pages: 1 - 11
Fertility drugs and the risk of breast cancer: a meta-analysis and review Tony G. ZreikAli MazloomBouthaina Dabaja Review 31 August 2010 Pages: 13 - 26
Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109 Alexandra HocklaDerek C. RadiskyEvette S. Radisky Preclinical study 25 December 2009 Pages: 27 - 38
UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs Wei JinYang LiuZhi-ming Shao Preclinical study 27 December 2009 Pages: 39 - 48
The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion Eun-Sook KimJae-Boon JeongAree Moon Preclinical study 01 January 2010 Pages: 49 - 61
17β-Estradiol enhances α5 integrin subunit gene expression through ERα–Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells Diego SisciEmilia MiddeaSebastiano Andò Preclinical study 06 January 2010 Pages: 63 - 77
Synergistic activity of letrozole and sorafenib on breast cancer cells Mara A. BonelliClaudia FumarolaPier Giorgio Petronini Preclinical study 07 January 2010 Pages: 79 - 88
The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells Selma MasriZheng LiuShiuan Chen Preclinical study 07 January 2010 Pages: 89 - 99
New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines Christelle ColinStéphane SalamoneStéphane Flament Preclinical study 07 January 2010 Pages: 101 - 110
Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue Emily WonLisa Wise-MilestoneCari M. Whyne Preclinical study 12 January 2010 Pages: 111 - 119
Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells Scott R. BurksLuciana F. MacedoJoseph P. Y. Kao Preclinical study 12 January 2010 Pages: 121 - 131
Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study Jens HuoberGunter von MinckwitzSibylle Loibl Clinical trial 10 August 2010 Pages: 133 - 140
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons Umberto VeronesiRoberto OrecchiaPatrick Maisonneuve Clinical trial 15 August 2010 Pages: 141 - 151
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study Robert E. ColemanLinda M. BanksLucy S. Kilburn Clinical trial 21 August 2010 Pages: 153 - 161
Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation Terry P. HainesPatricia SinnamonAmanda Smith Clinical trial 24 August 2010 Pages: 163 - 175
Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy Mark ClemonsAnil A. JoyKaren Gelmon Clinical trial 03 September 2010 Pages: 177 - 186
The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Zsolt GabosJohn ThomsBassam Abdulkarim Clinical trial 03 September 2010 Pages: 187 - 194
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers Susan M. DomchekTara M. FriebelTimothy R. Rebbeck Epidemiology 24 February 2010 Pages: 195 - 203
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors H. Irene SuMary D. SammelJun J. Mao Epidemiology 25 February 2010 Pages: 205 - 211
Are there racial/ethnic disparities among women younger than 40 undergoing mammography? Julie M. KappRod WalkerBonnie C. Yankaskas Epidemiology 04 March 2010 Pages: 213 - 222
The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis Lei YaoFang FangLong Yu Epidemiology 05 March 2010 Pages: 223 - 227
XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects Li-Xin QiuLei YaoXi-Chun Hu Epidemiology 05 March 2010 Pages: 229 - 235
Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population Jie LiangPeizhan ChenHongbing Shen Epidemiology 09 March 2010 Pages: 237 - 241
Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects Wenquan NiuYue QiDingliang Zhu Epidemiology 16 March 2010 Pages: 243 - 249
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics Monica ZuradelliBernard PeisselPaolo Radice Brief Report 07 April 2010 Pages: 251 - 258
Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer Thomas v. O. HansenLars JønsonFinn C. Nielsen Brief Report 01 May 2010 Pages: 259 - 264
TMS, a chemically modified herbal derivative of Resveratrol, induces cell death by targeting Bax Sarah E. AiyarHoyong ParkRichard J. Santen Brief Report 20 May 2010 Pages: 265 - 277
Angiosarcoma following MammoSite® partial breast irradiation Samuel AndrewsRebecca WilcoxonGeraldine Jacobson Brief Report 23 May 2010 Pages: 279 - 282
Mutation and association analysis of GEN1 in breast cancer susceptibility Clare TurnbullSarah HinesNazneen Rahman Brief Report 30 May 2010 Pages: 283 - 288
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk Christina JustenhovenStefan WinterHiltrud Brauch Letter to the Editor 05 August 2010 Pages: 289 - 292
Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis Konstantinos P. EconomopoulosTheodoros N. Sergentanis Letter to the Editor 05 August 2010 Pages: 293 - 294
Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation Jesús del ValleLídia FeliubadalóConxi Lázaro Letter to the Editor 13 August 2010 Pages: 295 - 296
